Patents by Inventor Ravi Ujjinamatada

Ravi Ujjinamatada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein kinase inhibitors
    Patent number: 10391082
    Abstract: A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (1) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: August 27, 2019
    Assignee: Orion Corporation
    Inventors: Tero Linnanen, Gerd Wohlfahrt, Srinivas Nanduri, Ravi Ujjinamatada, Srinivasan Rajagopalan, Subhendu Mukherjee
  • PROTEIN KINASE INHIBITORS
    Publication number: 20180250272
    Abstract: A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (1) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 6, 2018
    Inventors: Tero LINNANEN, Gerd WOHLFAHRT, Srinivas NANDURI, Ravi UJJINAMATADA, Srinivasan RAJAGOPALAN, Subhendu MUKHERJEE
  • PROTEIN KINASE INHIBITORS
    Publication number: 20160346254
    Abstract: A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Application
    Filed: August 9, 2016
    Publication date: December 1, 2016
    Inventors: Tero LINNANEN, Gerd WOHLFAHRT, Srinivas NANDURI, Ravi UJJINAMATADA, Srinivasan RAJAGOPALAN, Subhendu MUKHERJEE
  • Protein kinase inhibitors
    Patent number: 9447091
    Abstract: A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Grant
    Filed: October 9, 2012
    Date of Patent: September 20, 2016
    Assignee: ORION CORPORATION
    Inventors: Tero Linnanen, Gerd Wohlfahrt, Srinivas Nanduri, Ravi Ujjinamatada, Srinivasan Rajagopalan, Subhendu Mukherjee
  • PROTEIN KINASE INHIBITORS
    Publication number: 20160031855
    Abstract: A compound of formula (I) wherein R1 to R5, A, B, Z, Z1 and Z2 are as defined in the claims or a pharmaceutically acceptable salt thereof is disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Application
    Filed: April 3, 2014
    Publication date: February 4, 2016
    Applicant: Orion Corporation
    Inventors: Srinivasan RAJAGOPALAN, Prasad APPUKUTTAN, Karthikeyan NARASINGAPURAM ARUMUGAM, Ravi UJJINAMATADA, Shyie GEORGE, Tero LINNANEN
  • PROTEIN KINASE INHIBITORS
    Publication number: 20150011548
    Abstract: A compound of formula (I), wherein R3, R4, G, B, M, and Z are as defined in the claims, and pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as FGFR inhibitors and are useful in the treatment of a condition, where FGFR kinase inhibition is desired, such as cancer.
    Type: Application
    Filed: October 9, 2012
    Publication date: January 8, 2015
    Inventors: Tero Linnanen, Gerd Wohlfahrt, Srinivas Nanduri, Ravi Ujjinamatada, Srinivasan Rajagopalan, Subhendu Mukherjee